Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tucker

Showing results (241-250 of 466) with videos related to

Pageof 47
Sort By:
Clinical Pharmacokinetics|February 23, 2010
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearanceTrevor N Johnson, Koen Boussery, Karen Rowland-Yeo, et al.
Pharmacogenetics|August 1, 1993
Debrisoquine and metoprolol oxidation in Zambians: a population studyO O Simooya, E Njunju, A R Hodjegan, et al.
Biochemical Pharmacology|July 25, 1991
Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine typeM Adams, M S Lennard, S V Otton, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humansS R Peacey, A Rostami-Hodjegan, E George, et al.
European Journal of Clinical Pharmacology|January 1, 1981
A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patientsJ H Silas, F C Phillips, S Freestone, et al.
British Journal of Clinical Pharmacology|December 28, 2023
The British Journal of Clinical Pharmacology: The first 50 yearsSerge Cremers, Geoffrey T Tucker, Jeffrey K Aronson, et al.
Vitamins and Hormones|April 30, 2016
Klotho Is a Neuroprotective and Cognition-Enhancing ProteinC R Abraham, P C Mullen, T Tucker-Zhou, et al.
The American Journal of Physiology|May 12, 1998
Population-based modeling to demonstrate extrapancreatic effects of tolbutamideA Rostami-Hodjegan, S R Peacey, E George, et al.
Anesthesia and Analgesia|December 1, 1989
Disposition kinetics of ropivacaine in humansA Lee, D Fagan, M Lamont, et al.
Pharmacogenetics|September 2, 1999
A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotypeD Marez-Allorge, S W Ellis, J M Lo Guidice, et al.
Pageof 47

Showing results (241-250 of 466) with videos related to

Sort By:
Pageof 47
Clinical Pharmacokinetics|February 23, 2010
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearanceTrevor N Johnson, Koen Boussery, Karen Rowland-Yeo, et al.
Pharmacogenetics|August 1, 1993
Debrisoquine and metoprolol oxidation in Zambians: a population studyO O Simooya, E Njunju, A R Hodjegan, et al.
Biochemical Pharmacology|July 25, 1991
Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine typeM Adams, M S Lennard, S V Otton, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humansS R Peacey, A Rostami-Hodjegan, E George, et al.
European Journal of Clinical Pharmacology|January 1, 1981
A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patientsJ H Silas, F C Phillips, S Freestone, et al.
British Journal of Clinical Pharmacology|December 28, 2023
The British Journal of Clinical Pharmacology: The first 50 yearsSerge Cremers, Geoffrey T Tucker, Jeffrey K Aronson, et al.
Vitamins and Hormones|April 30, 2016
Klotho Is a Neuroprotective and Cognition-Enhancing ProteinC R Abraham, P C Mullen, T Tucker-Zhou, et al.
The American Journal of Physiology|May 12, 1998
Population-based modeling to demonstrate extrapancreatic effects of tolbutamideA Rostami-Hodjegan, S R Peacey, E George, et al.
Anesthesia and Analgesia|December 1, 1989
Disposition kinetics of ropivacaine in humansA Lee, D Fagan, M Lamont, et al.
Pharmacogenetics|September 2, 1999
A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotypeD Marez-Allorge, S W Ellis, J M Lo Guidice, et al.
Pageof 47